looking for the exceptions to the overall conclusion that surgery is superior. The SYNTAX score did not provide a predictive interaction although there was the expected trend for greater benefit of surgery in the patients with higher SYNTAX scores. All patients with diabetes and coronary artery disease were not included in the trial. That is the fact with all randomized trials. The surgical risk for patients needs to be an important consideration, as well as the extent of disease and the potential for nearcomplete revascularization by the 2 methods. The finding of the FREEDOM trial brings into focus the importance of the "Heart Team" approach to selection of therapy.
The new guidelines will be that surgery is better for diabetics. The judgment as to whether this rule should be followed or whether there are exceptions should be the consideration for each individual patient. Collaborative informed decision-making with the patient at the center will hopefully be strengthened by the outcome of this trial.
How should interventional cardiologists discuss the news with their patients? One-liners will not help. We should not deny the findings of this trial but embrace them as added information that helps us guide the appropriate decisions. Patients need to know that the trial was broadly inclusive and the results were the average. If the patient has specific conditions that make surgery or PCI problematic, they need to be discussed. Some studies show that patients are unaware that alternative therapies have been discussed prior to revascularization. This will not do in the future.
Most important for interventional cardiologists, surgeons, endocrinologists, primary physicians, and others caring for these patients is the commitment to optimal medical management which will be critical to the patient's long-term outcome. The patient must also understand that or all else is in vain. As we like to teach our children, with freedom comes responsibility. With the FREEDOM trial results, we have the responsibility to help guide the therapy of our patients for their ultimate benefit.
